Cameron Johnson (Phoenix Suns) with a deep 3 vs the Philadelphia 76ers, 04/21/2021
Cameron Johnson (Phoenix Suns) with a deep 3 vs the Philadelphia 76ers, 04/21/2021
Five Point Holdings, LLC ("Five Point" or the "Company") (NYSE:FPH), an owner and developer of large mixed-use, master-planned communities in California, today reported its first quarter 2021 results. Emile Haddad, Chairman and CEO, said, "Housing continues to be a bright spot of the economy. Strong demand for housing is being driven by low interest rates and people having a newfound appreciation for their homes and for how housing fits into their evolving lives. As evidence of this strong demand, year to date home sales at the Great Park Neighborhoods are over twice the amount of sales during the same period in 2020. The planning and amenities that go into our communities are embraced even more today than in past years. In Valencia, with approximately 60 model homes under construction, we are excited about our guest builders opening for sale and welcoming our first homeowners later this year."
ONEOK, Inc. (NYSE: OKE) will participate in the Citi Global Energy and Utilities Virtual Conference May 11-12, 2021.
UWM Holdings Corporation Announces First Quarter 2021 Results
Video game maker Roblox announced its Q1 2021 earnings for the first time as a public company.
company award logo (2).png company award logo (2).png SOUTHFIELD, MICHIGAN, May 10, 2021 (GLOBE NEWSWIRE) -- Xeeva, Inc., a global provider of data-driven spend management solutions, announced today that it was featured on CIO Applications’ list of the “Top 10 Procurement Solution Providers” for 2021. In its sixth annual edition, CIO Applications selected the top 10 procurement solution providers that are set to transform the supply chain management landscape and that can escalate the chances of organizational growth. During these times of change in our global economy, chief procurement officers are facing an increasingly complex landscape and must focus on managing and anticipating risk and embracing the need for greater transparency across the supply chain. The growing awareness of procurement’s potential is increasing the pressure to implement digital technologies like AI, data analytics, and automation. These innovative technologies are helping managers automate procurement tasks and increase profitability for their organizations by enhancing market visibility and turning procurement into a more strategic role. Xeeva was among the 10 companies chosen by CIO Applications because it empowers organizations to take control of their costs, improve compliance, reduce risk, and drive better bottom-line results. Its full spend management suite helps businesses transform procurement processes and reveals insights no other solution can see. Its solutions cleanse, categorize, and enrich indirect spend data to surface savings opportunities by category type and drive actual results across organizations’ indirect spend. “We are so proud to be recognized as one of the ‘Top 10 Procurement Solution Providers’ this year, said Nina Vellayan, President & CEO of Xeeva. We’ve worked very hard to make our solutions user-friendly and help our customers save money. With our AI-integrated platform, we can surface and deliver 10-30% savings in just 6 weeks with no implementation or launch fees and very minimal IT involvement. We continue to work on and to improve our solutions, and receiving this award is strong validation of our vision for procurement technology.” CIO Applications has recognized Xeeva multiple times over the years. In 2017, the spend management software company was included as one of the “Top 25 Procurement Solution Providers” award and was featured again in 2020 as one of the “Top Procurement Solution Providers.” To learn more about how Xeeva utilities cutting-edge technology to reduce a customer’s overall operating costs, check out this interview CIO Applications had with Xeeva’s VP of Product Management. To learn more about the “Top 10 Procurement Solution Providers 2021” award, click here. About CIO Applications CIO Applications is a technology print magazine, published from Fremont, CA that is a prime platform for CIOs to discuss and ponder about innovative enterprise solutions. While analyzing the U.S. media landscape, it is a comprehensive tool that helps the upcoming enterprise IT vendors to engage and showcase the solutions for the enterprises. It helps technology leaders with the analysis on new technologies and gives a better understanding of the role that enterprise solutions play in achieving the business goals. For more info: www.cioapplications.com. About Xeeva Xeeva is the leader in indirect spend management solutions that optimize the entire procurement process. From delivering unparalleled data quality and completeness to intelligent guided buying for managing complex procurement operations, take advantage of Xeeva’s unique combination of AI-powered technology, industry insights, and domain expertise to maximize your procurement efficiency and savings. Xeeva transforms indirect spend management with best practices around spend analytics, data enrichment, sourcing, and procure-to-pay solutions that drive better, more strategic decision-making and deliver real financial impact to the enterprise. For more information, visit www.xeeva.com. Contact Suhina Lal, Marketing Coordinator Xeeva, Inc. email@example.com ### Attachment company award logo (2).png CONTACT: Suhina Lal Xeeva, Inc. firstname.lastname@example.org
Happy Monday, Charlotte. Kristen here. Fun fact: today marks the 71st edition of the Afternoon Observer. It’s been a great time so far for me, and based on some feedback I’ve gotten from y’all, the feeling is mutual. How are you enjoying the newsletter? You can answer some questions from us here, or if you prefer, come straight to my inbox to let me know how you feel about it. I appreciate every bit of input from y’all. After all, the readers are who we do it all for.
Say hello to the ladies!
U.S. and Mexican unions on Monday filed the first labor complaint against Mexico under the U.S.-Mexico-Canada free trade pact. The complaint argues that Mexico has not lived up to its pledge under the trade accord, known as the USMCA, to guarantee workers the right to freely organize and join the union of their choice. The complaint centers on the Tridonex auto parts assembly plant in the Mexican border city of Matamoros where workers have been fighting to join a new union.
A new analysis of opioids in West Virginia shows the city of Huntington and its surrounding county were overwhelmed with shipments of prescription drugs, nearly all of which came from three large drug distributors on trial in a landmark case. According to McCann, an analysis of data showed that from 2006 to 2014, about 110 million doses of hydrocodone and oxycodone were shipped to Cabell County and Huntington, which accuse the three distributors in federal court of fueling the area's opioid epidemic.
KKR Real Estate Finance Trust Inc. ("KREF") (NYSE: KREF) today announced that KKR REFT Holdings L.P., a subsidiary of KKR & Co. Inc. (the "KKR Stockholder"), has agreed to sell in an underwritten secondary offering a total of 5,000,000 shares of KREF common stock (the "Offering"). In addition, the KKR Stockholder has agreed to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of KREF common stock (the "Overallotment Option"). KREF is not selling any shares in connection with, and will not receive any proceeds from, the Offering. The KKR Stockholder will receive all of the net proceeds from the Offering.
This morning ServiceNow announced that it was acquiring Lightstep, an applications performance monitoring startup that has raised over $70 million, according to Crunchbase data. The companies did not share the acquisition price. ServiceNow wants to take advantage of Lightstep's capabilities to enhance its IT operations offerings.
i3 Verticals, Inc. (Nasdaq: IIIV) ("i3 Verticals" or the "Company") today reported its financial results for the fiscal second quarter ended March 31, 2021.
A preliminary report by the National Transportation Safety Board raises the possibility that one of two key components of Tesla Inc.'s Autopilot may not have been engaged during a fiery crash in Texas last month.
Lisa Mao was killed in an accident at the San Gabriel Mountains in California that also left her 4-year-old daughter, Nova, in a medically induced coma
Palantir reports first quarter earnings before the market open on Tuesday. After a hot initial offering, Palantir stock has swooned amid a broad decline in software growth stocks in 2021.
Lille, France; Cambridge, MA; May 10, 2021 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases (the “Company”), today announced that it published in the May 10, 2021 French legal announcements bulletin n°56 (Bulletin des Annonces Légales Obligatoires) its convening notice that the Combined Shareholders Meeting will be held on June 15, 2021, at 2:30pm, at the Company’s headquarters, located at Parc Eurasanté, 885 avenue Eugène Avinée in Loos (59120), France. Due to the ongoing COVID-19 pandemic and in accordance with emergency measures imposed by the French government, the Board of Directors of the Company has decided that the Combined General Meeting will be conducted behind closed doors at the Company’s headquarters located at Parc Eurasanté, 885 Avenue Eugène Avinée, Loos (59120), France, without the physical presence of shareholders and others who are usually entitled to attend. The convening notice published in the May 10, 2021 French legal announcements bulletin n°56 (Bulletin des Annonces Légales Obligatoires) and available in the Investors & Media section of the Company’s website (https://ir.genfit.com/financial-information/shareholders-meeting) outlines the procedures by which shareholders may participate in the Meeting notwithstanding the exceptional measures required in order to comply with regulatory constraints and ensure the health and safety of our shareholders. Shareholders may provide their voting instructions via the Internet through the VOTACCESS platform. A tutorial to familiarize shareholders with this online voting platform will be available in the same section of the website, as well as a toll-free (France only) number to call with any questions regarding how to participate in the Meeting. Documentation regarding the Meeting will be available to shareholders in accordance with existing regulations, and available on the Company’s website, in the Investors & Media section (https://ir.genfit.com/financial-information/shareholders-meeting). ABOUT GENFIT GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with cholestatic and metabolic chronic liver diseases. GENFIT is a pioneer in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. GENFIT is currently enrolling in ELATIVE™, a Phase 3 clinical trial evaluating elafibranor in patients with Primary Biliary Cholangitis (PBC). Elafibranor is an investigational compound that has not been reviewed and has not received approval by any regulatory authority. As part of GENFIT’s comprehensive approach to clinical management of patients with liver disease, the Company is also developing NIS4®, a new, non-invasive blood-based diagnostic technology which could enable easier identification of patients with at-risk NASH. NIS4® technology has been licensed to LabCorp® in the U.S. and Canada for the development and commercialization of a blood-based molecular diagnostic test powered by NIS4® technology. GENFIT has facilities in Lille and Paris, France, and Cambridge, MA, USA. GENFIT is a publicly traded company listed on the Nasdaq Global Select Market and on compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com FORWARD LOOKING STATEMENTS This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including “consider”, “contemplate”, “think”, “aim”, “expect”, “understand”, “should”, “aspire”, “estimate”, “believe”, “wish”, “may”, “could”, “allow”, “seek”, “encourage” or “have confidence” or (as the case may be) the negative forms of such terms or any other variant of such terms or other terms similar to them in meaning is intended to identify forward-looking statements. Although the Company believes its projections are based on reasonable expectations and assumptions of the Company’s management, these forward-looking statements are subject to numerous known and unknown risks and uncertainties, which could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including in relation to safety, biomarkers, progression of, and results from, its ongoing and planned clinical trials, review and approvals by regulatory authorities of its drug and diagnostic candidates, exchange rate fluctuations and the Company’s continued ability to raise capital to fund its development, as well as those risks and uncertainties discussed or identified in the Company’s public filings with the AMF, including those listed in Chapter 2 “Main Risks and Uncertainties” of the Company’s 2020 Universal Registration Document filed with the AMF on 23 April 2021 under n° D.21-0350, which is available on the Company’s website (www.genfit.com) and on the website of the AMF (www.amf-france.org) and public filings and reports filed with the U.S. Securities and Exchange Commission (“SEC”) including the Company’s 2020 Annual Report on Form 20-F filed with the SEC on April 23, 2021. In addition, even if the Company’s results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. These forward-looking statements speak only as of the date of publication of this document. Other than as required by applicable law, the Company does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. CONTACT GENFIT | Investors Tel: +1 (617) 714 5252 | email@example.com PRESS RELATIONS | Media Hélène LAVIN – Press relations | Tel: +333 2016 4000 | firstname.lastname@example.org GENFIT | 885 Avenue Eugène Avinée, 59120 Loos - FRANCE | +333 2016 4000 | www.genfit.com Attachment GENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Preparatory Documents
SiriusPoint Ltd. ("SiriusPoint" or the "Company") (NYSE:SPNT) today announced results for its first quarter ended March 31, 2021.
Delivered strong results with an Adjusted EBITDA improvement of 9% year-over-year HOLLYWOOD, FL, May 10, 2021 (GLOBE NEWSWIRE) -- Healthier Choices Management Corp. (OTC Pink: HCMC) today announced its financial results for the three-month period ended March 31, 2021. First Quarter 2021 Results and Highlights: Net sales from operations amounted to approximately $3.5 million, down 14% from the same period last year; a significant portion of the decline related to last March’s COVID-19 sales surge in the grocery segment. Total operating expense was approximately $2.0 million for the three months ended March 31, 2021; a decrease of 15%. Net loss from operations was approximately $696,000; a 1% decline from the prior year. Adjusted EBITDA loss amounted to $394,000, an improvement of approximately 9% when compared to the same period last year. Jeffrey Holman, Chairman and Chief Executive Officer of Healthier Choices Management Corp., said, “We are pleased with our first quarter results which reflect the normalizing of sales and the increasingly improving momentum of our operating cost reductions.” Mr. Holman concluded, “We continue with our commitment to better the fundamentals of our operations. The progress made is largely attributable to simplifying our structure and sharpening our focus, and we believe that our businesses are well poised to continue delivering operational improvement.” About Healthier Choices Management Corp. Healthier Choices Management Corp. (www.healthiercmc.com) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. Through its wholly owned subsidiary HCMC Intellectual Property Holdings, LLC, the Company manages and intends to expand on its intellectual property portfolio. The Company currently operates eight retail vape stores in the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company also operates Ada’s Natural Market, a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc. and Paradise Health and Nutrition, stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items through its wholly owned subsidiary Healthy Choice Markets 2, LLC. The Company also sells vitamins and supplements on its website TheVitaminStore.com. The Company markets its Q-Cup™ technology under the vape segment. This patented technology is based on a small, quartz cup called the Q-Cup™, which a customer can purchase already filled by a third party in some regions, or can partially fill themselves with either cannabis or CBD concentrate (approximately 50mg), also purchased from a third party. The Q-Cup™ can then be inserted into the patented Q-Unit™, which heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ and Q-Unit™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. The Q-Cup™ can also be used in other devices as a convenient micro-dosing system. These products are available on the Company’s website at www.TheQcup.com. Forward Looking Statements. This press release contains forward looking statements within the meaning of that term in the Private Securities Litigation Reform Act of 1995 (Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Additional written or oral forward looking statements may be made by the Company from time to time in filings with the Securities and Exchange Commission (SEC) or otherwise. Statements contained in this press release that are not historical facts are forward looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and are based on management's estimates, assumptions and projections and are not guarantees of future performance. The Company assumes no obligation to update these statements. Forward looking statements may include, but are not limited to, projections or estimates of revenue, income or loss, exit costs, cash flow needs and capital expenditures, statements regarding future operations, expansion or restructuring plans, including our recent exit from and winding down of our wholesale distribution operations. In addition, when used in this release, the words "anticipates," "believes," "estimates," "expects," "intends," and "plans" and variations thereof and similar expressions are intended to identify forward looking statements. Factors that may affect our future results of operations and financial condition include, but are not limited to, fluctuations in demand for our products, the introduction of new products, our ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of our liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in our filings with the SEC. Contact Information: Healthier Choices Management Corp. 3800 North 28th Way, #1 Hollywood, FL 33020Office: 305-600-5004 / Fax: 954-272-7773Website: www.HealthierCMC.comEmail: email@example.com Results of Operations The following table sets forth our Condensed Consolidated Statements of Operations for the three-months ended March 31, 2021 and 2020: HEALTHIER CHOICES MANAGEMENT CORP.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(UNAUDITED) Three Months Ended March 31, 2021 2020 Total sales, net $3,465,753 $4,036,171 Total cost of sales 1,975,043 2,328,280 GROSS PROFIT 1,490,710 1,707,891 Total operating expenses 2,210,324 2,372,381 LOSS FROM OPERATIONS (719,614) (664,490) Total other income (expense), net (46,789) (26,804) NET LOSS FROM CONTINUING OPERATIONS $(766,403) $(691,294) See non-GAAP financial measure discussion Three Months Ended March 31, 2021 2020 Adjusted EBITDA Loss from operations $(719,614) $(664,490)Depreciation and amortization 136,597 147,834 Stock compensation 20,623 81,944 Adjusted EBITDA $(562,394) $(434,712) Consolidated Balance Sheets The following table sets forth our Condensed Consolidated Balance Sheets for the periods ended March 31, 2021 and December 31, 2020: HEALTHIER CHOICES MANAGEMENT CORP.CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2021 December 31, 2020 (UNAUDITED) ASSETS CURRENT ASSETS Cash and cash equivalents $5,316,169 $925,475 Other current assets 2,044,226 2,081,717 TOTAL CURRENT ASSETS 7,360,395 3,007,192 Other assets 6,625,142 8,867,801 TOTAL ASSETS $13,985,537 $11,874,993 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Other current liabilities $2,326,443 $5,654,096 TOTAL CURRENT LIABILITIES 2,326,443 5,654,096 Other liabilities 3,779,746 3,963,529 TOTAL LIABILITIES 6,106,189 9,617,625 COMMITMENTS AND CONTINGENCIES (SEE NOTE 10) - - TOTAL STOCKHOLDERS’ EQUITY 7,879,348 2,257,368 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $13,985,537 $11,874,993 Non-GAAP – Financial Measure The following discussion and analysis contains a non-GAAP financial measure. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles (GAAP). Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternative to, net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. Non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive of potential future financial results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP. Management believes stockholders benefit from referring to the Adjusted EBITDA in planning, forecasting, and analyzing future periods. Management uses this non-GAAP financial measure in evaluating its financial and operational decision making and as a means of evaluating period to period comparison. We define Adjusted EBITDA as net loss from operations adjusted for non-cash charges from depreciation and amortization and stock compensation. Management believes Adjusted EBITDA is an important measure of our operating performance because it allows management, investor and analysts to evaluate and assess our core operating results from period to period after removing the impact of significant non-cash charges that effect comparability between reporting periods. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items. We have included a reconciliation of our non-GAAP financial measure to loss from operations as calculated in accordance with GAAP. We believe that providing the non-GAAP financial measure, together with the reconciliation to GAAP, helps investors make comparisons between the Company and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to specific definition being used and to the reconciliation between such measures and the corresponding GAAP measure provided by each company under applicable rules of the Securities and Exchange Commission (“SEC”).
Governor’s policy singles out religious gathering in a manner inconsistent with recent Supreme Court decisionsBOSTON, May 10, 2021 (GLOBE NEWSWIRE) -- On behalf of New Life South Coast in New Bedford, Massachusetts, First Liberty Institute, the Massachusetts Family Institute, and the global law firm Jones Day, today filed a lawsuit against Massachusetts Governor Charlie Baker, New Bedford Mayor Jonathan Mitchell, and several other officials seeking to block commonwealth-wide COVID standards that single out churches for disfavored treatment. The church filed the complaint in the United States District Court for the District of Massachusetts. You can read the complaint here. “A year into the pandemic and after several Supreme Court decisions, the Governor and New Bedford officials continue to act like only secular businesses are essential. It’s past time for state and local officials to stop treating houses of worship unequally,” said Andrew Beckwith, president of the Massachusetts Family Institute. “The Governor’s and Mayor’s policies seem more calibrated to contain the free exercise of religion than the spread of COVID-19,” said Jordan Pratt, Senior Counsel at First Liberty. “The state and city single out places of worship for differential and disfavored treatment. The Supreme Court has spoken loud and clear at least 7 times that churches are essential and must be treated fairly,” said Christopher DiPompeo of Jones Day. In March, Governor Charlie Baker issued Order 66, which advanced the Commonwealth to Phase IV, Step 1 of reopening protocols effective March 22, 2021. Order 66 provides that churches and other places of worship “may open [their] premises to workers and the public” so long as such places of worship follow the Director of Labor Standards’ Sector Specific Workplace Standards for Places of Worship and Religious Services to Address COVID-19. Under the Phase IV standards—which are subject to the Governor’s approval—laboratories, manufacturing facilities, restaurants, coffee shops, and public transportation have no capacity restrictions beyond the practical constraints of social-distancing, while places of worship must follow more burdensome special capacity restrictions. According to the complaint, “Under [current] regulations, restaurants, theaters, public transit, and other places of public gatherings have limited or no restrictions on capacity, beyond the practical constraints of social distancing, while places of worship must follow more burdensome capacity restrictions. Massachusetts’ regulations on places of worship are unlawful. The Supreme Court’s recent opinion in Tandon v. Newsom makes clear that, where less onerous COVID-19-related regulations suffice for comparable secular activities, those same regulations suffice for religious activities. Massachusetts’ regulations fail this standard. The regulations make it easier to meet at Applebee’s or an AMC theater than at New Life. This cannot stand.” About First Liberty Institute First Liberty Institute is a non-profit public interest law firm and the largest legal organization in the nation dedicated exclusively to defending religious freedom for all Americans. To arrange an interview, contact Lacey McNiel at firstname.lastname@example.org or by calling 972-941-4453. Contact: Lacey McNiel, email@example.com Direct: 972-941-4453
Crawford Technologies, provider of innovative document solutions that streamline, improve and manage customer communications, and BlueRush, an emerging personalized video Software as a Service (SaaS) company, are partnering to produce personalized contextual video bills and statements. Working together, the companies are introducing the industry's first ability to deliver personalized video bills and statements built from data contained in any transactional document.